DnB Asset Management’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$214K Buy
9,253
+1,488
+19% +$34.4K ﹤0.01% 694
2025
Q1
$210K Buy
7,765
+1,987
+34% +$53.6K ﹤0.01% 705
2024
Q4
$309K Sell
5,778
-475
-8% -$25.4K ﹤0.01% 685
2024
Q3
$284K Buy
6,253
+980
+19% +$44.5K ﹤0.01% 681
2024
Q2
$221K Buy
+5,273
New +$221K ﹤0.01% 692